Perinatal Mental Health Study (PMHS) India
PMHS
1 other identifier
observational
2,332
1 country
2
Brief Summary
The purpose of this observational study is to improve understanding of mental disorders among perinatal women in India.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2022
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 1, 2022
CompletedFirst Posted
Study publicly available on registry
August 3, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2026
ExpectedDecember 7, 2023
November 1, 2023
3 years
August 1, 2022
November 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Phase 1: Codes and themes relating to acceptability of screening for perinatal mental disorders
These will be themes emerging from focus groups with women around awareness of perinatal mental disorders and acceptability of screening.
To be completed by August 2022
Phase 2: Psychometric properties of screening tools for common mental disorders
The psychometric properties (sensitivity, specificity, area under the receiver operating curve, optimal cut-off and accuracy) of eight screening tools in Kannada and Hindi will be established among three groups of women: pregnant, post-partum and non-perinatal.
September 2022 - August 2023
Phase 3: Point prevalence, period prevalence and incidence (with 95% confidence intervals) of common mental disorders among perinatal and non-perinatal women
During the cohort study, prevalence and incidence of mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.
September 2023 - August 2024
Phase 3: Odds ratios (with 95% confidence intervals) for factors associated with common mental disorders among perinatal and non-perinatal women
During the cohort study, risk factors associated with mental disorders (depression, anxiety, PTSD, somatisation and suicidality) will be assessed.
September 2023 - August 2024
Study Arms (2)
Perinatal women
Women will be recruited in their first trimester of pregnancy and followed-up until 6 months post-partum. This is the 'exposed' group.
Non-perinatal women
Non-perinatal women will be recruited as the 'non-exposed' group and followed-up over the same duration as the perinatal group.
Interventions
A number of screening tools will be administered which will establish the likelihood of depression, anxiety, PTSD, somatisation and suicidality.
Eligibility Criteria
Study participants are women aged 18-45 years living in two low-income settings who fall into one of the following groups: (i) pregnant women: women who are pregnant (any trimester of pregnancy) (ii) post-partum women: women who are within 12 months post-partum (iii) non-perinatal women: women who are not currently pregnant and have not given birth within the past 12 months
You may qualify if:
- For Phase 1 (qualitative study) and Phase 2 (validation study):
- Pregnant women:
- Aged 18 to 45 years
- Currently pregnant (any trimester)
- Willing and able to give informed consent
- Post-partum women:
- Aged 18 to 45 years
- Currently post-partum (between 1-12 months postpartum)
- Willing and able to give informed consent
- Non-perinatal women:
- Aged 18 to 45 years
- Not currently pregnant and not given birth in the past 12 months
- Willing and able to give informed consent
- For Phase 3 (prospective cohort study):
- Perinatal women:
- +11 more criteria
You may not qualify if:
- The participant may not enter the study if:
- They have an acutely severe psychiatric illness which impairs their ability to take part in the study
- They are not willing or able to provide informed consent
- Other than for current severe psychiatric illness which affects ability to participate in the study, we will not exclude any participant on the basis of current or prior physical, psychological or psychiatric co-morbidities so long as she is willing to participate, her ability to take part is not compromised and her ability to give informed consent is not impaired by these conditions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Dr Rajendra Prasad Government Medical College
Kangra, Himachal Pradesh, India
National Institute of Mental Health and Neuro Sciences
Bengaluru, Karnataka, India
Related Publications (1)
Fellmeth G, Kishore MT, Verma A, Desai G, Bharti O, Kanwar P, Singh S, Thippeswamy H, Chandra PS, Kurinczuk JJ, Nair M, Alderdice F. Perinatal mental health in India: protocol for a validation and cohort study. J Public Health (Oxf). 2021 Oct 8;43(Suppl 2):ii35-ii42. doi: 10.1093/pubmed/fdab162.
PMID: 34622290BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gracia Fellmeth, DPhil
University of Oxford
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 1, 2022
First Posted
August 3, 2022
Study Start
September 1, 2022
Primary Completion
August 31, 2025
Study Completion (Estimated)
August 31, 2026
Last Updated
December 7, 2023
Record last verified: 2023-11